Accessibility links Skip to main content

Farma Consulting ? eBR Implementations

Over the past year, our consultants Sofie and Thomas have been working for one of our clients on the implementation of an electronic batch records system. Curious about their experiences? Read on to find out more!

Contact us

Fill out the form and we will contact you shortly.

Naam
Privacy Policy 
Continue reading

What was your role in the project?

Thomas: I was part of the project team as the QA lead. In this role, I was involved in discussions about how we would design the system, right through to the final documentation of this approach in procedures and work instructions.

Sofie: I served as Technical Writer, providing support in delivering the necessary documentation and conducting theoretical and practical training for end users.

What were the main challenges?

Thomas: Since this is a multi-use facility, both experimental and clinical batches can be manufactured there. The biggest challenge for us as the QA department was to maintain a balance between the flexibility required for experimental batches and the level of compliance required for clinical batches. That’s why we conducted an end-to-end risk analysis of the clinical batch manufacturing process within the system to ensure that all compliance requirements were defined and addressed in a structured manner.

Sofie: With regard to documentation, I think the biggest challenge in the initial phase was motivating and guiding all authors to invest time in getting to know the system, discussing concepts with other stakeholders, and starting to draft all procedures. As with all new things, the beginning is always the hardest. In the next stage, we organized joint review sessions so that all comments could be addressed immediately with the entire team.

What did you learn during the project?

Thomas: One of the great opportunities I had during this project was attending a training session provided by the MES system vendor. During this training, I was able to learn a lot about the system and how the software works.

Sofie: I gained a lot of knowledge about the software itself and its practical application in a dynamic context where we must comply with clinical regulations while still remaining flexible for development work at the plant.

In the meantime, the first clinical batches have been produced using an electronic batch record. Kudos for the great collaboration with the Janssen project team.

Feel free to contact us to discuss how we can support your company in digitizing your batch record system!

Your partner in quality, safety, and compliance

The life sciences sector requires specialized knowledge and reliable guidance. Thanks to our extensive expertise, we help organizations comply with laws and regulations, ensure quality, and continue to innovate with confidence.

Related services

Medical Team Performing Surgical Operation in Bright Modern Operating Room

Quality Management System (QMS)

Program and Project Management

Related Articles

10 Jul 2026

Project Management

In the complex and highly regulated world of the pharmaceutical industry, project management plays a pivotal role to bring life-saving medications and treatments to the market. From drug discovery to clinical trials and regulatory approval, effective project management is essential for managing timelines, resources, and compliance. Let’s dive in some practical tips and tricks specifically for navigating the complexities of project management in the pharmaceutical sector.

10 Jul 2026

Potential Pitfalls in an MES Project

Just as every project has its pitfalls, the same is true for a Manufacturing Execution System (MES) implementation project. Implementing electronic batch records is no easy task. That’s why, in the blog below, we’ll share a few pitfalls so you can prepare for a successful implementation within your company.

10 Jul 2026

Streamlining Post-Marketing Surveillance with IMDRF Coding

Since the implementation of the Medical Device Regulation (MDR) in Europe, companies have had to maintain and execute a post-marketing surveillance (PMS) procedure. This systematic process involves collecting and analysing data on the performance and safety of medical devices after they have been released to the market. The primary goal is to help manufacturers identify and address potential issues that may arise during actual use, monitor the market for known risks, and identify new risks.

10 Jul 2026

ISO 9001:2015 in Life Sciences Industry

In the life sciences industry, maintaining high quality standards is critical not only to the success and sustainability of organizations but also to patient safety and compliance. ISO 9001:2015, part of the ISO 9000 family, provides a robust framework for quality management systems (QMS) that can be used in organizations in the life sciences, including pharmaceutical, natural technology, including medical devices. This article examines the key features of ISO 9001:2015, its benefits, implementation methods, potential pitfalls, and impact in the life sciences.

10 Jul 2026

The Role of a CQV Expert in the Cold Chain Division of a Pharmaceutical Company

In the pharmaceutical industry, product quality is of vital importance. This is particularly true for medicinal products that are sensitive to temperature fluctuations, such as vaccines, biologics, and certain medications that must be stored and transported in a controlled environment. Within this process, the CQV (Commissioning, Qualification, and Validation) expert plays a crucial role, especially within the cold chain division, which is responsible for monitoring product quality during the transport and storage of these temperature-sensitive products. This blog outlines the various aspects a CQV expert must consider in this context.

10 Jul 2026

Radiopharmaceutical & Selective Internal Radiation Treatments: Overcoming Challenges and Embracing Future Opportunities

Radiopharmaceutical and selective internal radiation treatments have emerged as a transformative force in the pharmaceutical industry, offering precision, personalized therapies for patients with conditions such as cancer and other serious diseases.

10 Jul 2026

Implementation of the European Clinical Trial Regulation (EU-CTR)

By the end of this month (31st of January 2025), the final deadline is reached in the transition period for the implementation of the European Clinical Trial Regulation (EU-CTR). What is it and what is the difference with the previous European Clinical Trial Directive (EU-CTD)?